Mahler, Donald A. et al
"Once-daily QVA149 demonstrates superior improvements in patient-reported dyspnea compared to tiotropium in patients with moderate-to-severe COPD: The BLAZE study." European Respiratory Journal
42.Suppl 57
(2013):
P3635.
Web. 04 July. 2022.
